Why the backflip?

Jarrod McMaugh shares his concerns about Sonic’s withdrawal from Sigma’s in-pharmacy pathology screening program The news is extremely disappointing, and I feel it amounts to suppression of competition within the health sector. Competition is healthy in all areas of society, including the health sector. While the primary purpose of Amcal and Sonic's agreement was to